Pepper Bio’s Post

Interesting interview by Fiona Behan PhD, GSK’s scientific director of target discovery, on combinatorial #CRISPR screens as powerful discovery tool. We couldn’t agree more to the fact that ➡ combinatorial CRISPR screening identifies complex dependencies/vulnerabilities in cancer ➡ sophisticated AI/ML approaches are needed to full reap the wealth of data generated by combinatorial screens ➡ thorough validation processes for identified targets are key to forwarding screening hits to the clinic At Vivlion, we aim to bring combinatorial CRISPR screening and analysis tools into every target discovery pipeline. Our multiplex CRISPR libraries can be tailored to any project needs and come in any dimension and format (all-by-all or fixed gene combinations). Regardless if you are a novice to combinatorial CRISPR screening or looking for a reliable partnership for your screening and analysis needs – do not hesitate to reach out and discuss your project with us! #PRCISR #CRISPR #mpxCRISPR #SyntheticGenes #targetdiscovery

Endogenous retroviruses mediate transcriptional rewiring in response to oncogenic signaling in colorectal cancer Science Advances https://lnkd.in/gwUg4y7U

📰 “Damaged DNA in Colorectal Cancer Chemo Patients Might Be Repaired More Effectively with New Therapy” An international research team from the University of Oxford and Nanyang Technological University (NTU Singapore) reports the discovery of a new process for repairing damaged #DNA that is particularly relevant for patients undergoing colorectal #cancertreatments. 🔗Continue reading: https://bit.ly/4esJKkM University of Oxford Nanyang Technological University Singapore #LymphocyteEngineering #CART #Immunotherapy #PrecisionMedicine #CellTherapy #GeneEditing

HNL Lab Medicine is proud to support Dr. Nair and Dr. Toor as they lead the way in advancing cellular therapies for cancer treatment. Check out the insights shared in this article to learn more about this exciting program at LVHN! #HNL #cancerresearch #cellulartherapies #medicaladvancements

🔬 Comprehensive Analysis of TP53 Dysregulation in Cancer  Explore our study on the pivotal role of TP53 in cancer progression and patient survival, leveraging data from extensive datasets like TCGA. Uncover the prognostic significance of TP53 expression and its potential as a therapeutic target. 🧬 #CancerResearch #TP53 #Bioinformatics [Read the article]

Here’s your Daily Biomedic Dose 😊 An interesting 4 mins read: How early-stage cancer cells hide from the immune system. (Massachusetts Institute of Technology) #dailybiomedicdose #clincialtrial #biomedicalresearch #research #biomedicalscience #hcpc #ibms #mls #medicallaboratoryscience #nhs

GPS nanoparticle platform precisely delivers therapeutic payload to cancer cells

With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies. | Click below to read the full article on Sunalei

Chinese Medical Journal Review highlights novel pathogenic mechanisms and therapeutic potentials in cancer treatment targeting internal N6-methyladenosine and N7-methylguanine

Nucleai will showcase its developments in cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, California from April 5-10, 2024. https://lnkd.in/dFnFQZCZ 🚀Follow us now for more exclusive content & updates!💡 #dailydose #followus #staytuned #stayconnected #technews #technology #trending #trendingreels #viral #viralreels #viralvideo #trendingnow #trendingreels #trendingnews #explore #explorepage #techdogs